Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial
Titel:
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial
Auteur:
Lombardi, Giuseppe De Salvo, Gian Luca Brandes, Alba Ariela Eoli, Marica Rudà , Roberta Faedi, Marina Lolli, Ivan Pace, Andrea Daniele, Bruno Pasqualetti, Francesco Rizzato, Simona Bellu, Luisa Pambuku, Ardi Farina, Miriam Magni, Giovanna Indraccolo, Stefano Gardiman, Marina Paola Soffietti, Riccardo Zagonel, Vittorina